首页> 美国卫生研究院文献>Saudi Pharmaceutical Journal : SPJ >Experimental and theoretical study on structure-tautomerism among edaravone isoxazolone and their heterocycles derivatives as antioxidants
【2h】

Experimental and theoretical study on structure-tautomerism among edaravone isoxazolone and their heterocycles derivatives as antioxidants

机译:依达拉奉异恶唑酮及其杂环衍生物作为抗氧化剂的结构互变异构现象的实验和理论研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Edaravone is a heterocyclic pyrazolone compound. It has pronounced effect against free radicals, however renal and hepatic disorders have been reported. Isoxazolones are considered bioisosteric analogues of pyrazolones and may have comparable properties. Thus, we investigated the structural and electronic influences for edaravone, isoxazolone, and their tautomers on antioxidant process. Structure and tautomerism study among edaravone, isoxazolone and their heterocycles derivatives were related to antioxidant mechanisms by using the hybrid DFT method B3LYP with the basis sets 6-31++G(2d,2p). The C—H tautomer was the most stable and energetically favored among them. Intramolecular N—H—N hydrogen bonds and polar medium were responsible for the low energy differences among all possible tautomers. N—H tautomers in both systems proved to be better antioxidant by SET (single electron transfer), while O—H tautomers were better antioxidant on HAT (homolytic hydrogen atom transfer) mechanism. Theoretical calculation showed that edaravone is more potent than phenylisoxazolone, however, both has similar antioxidant scavenging on experimental DPPH. The carbonyliminic system played a very important role in the antioxidant activity for both studied classes.
机译:依达拉奉是杂环吡唑啉酮化合物。它对自由基具有明显的作用,但是据报道有肾脏和肝脏疾病。异恶唑酮被认为是吡唑啉酮的生物立体异构体,可能具有可比的特性。因此,我们研究了依达拉奉,异恶唑酮及其互变异构体在抗氧化剂过程中的结构和电子影响。依达拉奉,异恶唑酮及其杂环衍生物之间的结构和互变异构现象的研究与采用6-31 ++ G(2d,2p)基集的杂交DFT方法B3LYP有关。 CH互变异构体是其中最稳定,最受能量欢迎的异构体。分子内NH-NH氢键和极性介质是所有可能互变异构体之间低能差的原因。在两个系统中,NH互变异构体通过SET(单电子转移)证明是更好的抗氧化剂,而OH互变异构体在HAT(均溶氢原子转移)机理上是更好的抗氧化剂。理论计算表明,依达拉奉比苯基异恶唑酮更有效,但两者在实验DPPH上具有相似的抗氧化剂清除能力。对于这两个研究类别,羰基亚胺基系统在抗氧化活性中起着非常重要的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号